Global Health Headlines: TB, Bird Flu, and Big Pharma Moves

Current health news highlights a 10% rise in child TB infections in Europe, a new drug review by European regulators, the spread of bird flu to sheep in the UK, US egg import changes amid bird flu fears, and a bankruptcy filing by 23andMe. Major pharmaceutical actions are also noted.

The World Health Organization has reported a significant 10% rise in tuberculosis infections among children in the European region, emphasizing the urgent need for public health measures. The increase was noted across 53 countries, with over 7,500 cases detected in 2023, surpassing previous years' figures.

In pharmaceutical news, the European Medicines Agency is evaluating GSK's asthma drug, Nucala, for its efficacy in treating chronic obstructive pulmonary disease (COPD). Previous studies indicate a favorable outcome for those combining Nucala with traditional inhaled maintenance therapies.

Concerns about avian influenza, commonly known as bird flu, continue to grow as the UK detects its first case in a sheep. The spread of the virus to various mammals and the potential for human transmission heightens the fear of a global pandemic.

(With inputs from agencies.)